The effects of empagliflozin on hepatic parameters and liver fat content in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
Background: Type 2 Diabetes Mellitus (T2DM) often coexists with hepatic complications, including Non-Alcoholic Fatty Liver Disease (NAFLD), posing significant challenges in treatment strategies. Empagliflozin, a Sodium-Glucose Co-Transporter 2 (SGLT2) inhibitor, has garnered attention for managing T...
| Main Author: | |
|---|---|
| Format: | Thesis |
| Language: | English |
| Published: |
2024
|
| Subjects: | |
| Online Access: | http://eprints.usm.my/62576/ http://eprints.usm.my/62576/1/Lim%20Kar%20Ying-E.pdf |